LP.8.1 variant adapted COVID-19 vaccine COMIRNATY is now authorized in Canada for individuals 6 months of age and older. It is expected to be available in Canada in the coming weeks. This season's ...

With the approval of ABRYSVO® for adults aged 18+, there is now a way to help protect against RSV in a population that previously did not have vaccination options. KIRKLAND, QC, Oct. 21, 2025 /CNW/ - ...

MONTREAL, CANADA – Pfizer Canada’s pharmaceutical division is among Canada’s best companies to work for, says a closely watched annual survey by Report on Business Magazine. The magazine, published by ...

Pfizer's Canadian unit and BioNTech said they have received approval in Canada for their updated Comirnaty Covid-19 vaccine. The companies said Monday the updated vaccine targets the Omicron LP.8.1 ...

Pfizer Inc. (NYSE:PFE) announced that its Phase 3 TALAPRO-3 clinical trial met its primary endpoint, demonstrating that the ...

(RTTNews) - Pfizer Canada ULC and BioNTech SE (BNTX) announced that Health Canada has authorized the LP.8.1 variant adapted COMIRNATY COVID-19 vaccine for individuals aged 6 months and older. The ...

Canadians looking to get a COVID-19 vaccine at local pharmacies may run into some trouble. Pfizer Canada says it has placed temporary limits on orders of one of its COVID shots at community pharmacies ...

OTTAWA, Nov 8 (Reuters) - Canada's Supreme Court struck down the patent on global pharmaceuticals giant Pfizer Inc's Viagra erectile dysfunction drug on Thursday and opened the door to generic ...

This week, the FDA approved a label change on Depo Provera, requiring its maker, Pfizer, to warn women about links between use of the birth control injection and brain tumors known as meningiomas.